Tag: cha biotech

cha biotech

Latest News

CHA Biotech's U.S. arm launches CDMO platform, bags first client

New manufacturing system shortens gene therapy development timelines and improves client collaboration.

2026.6.17

Matica Biolabs CEO Jang Won-gyu, left, and TiCARos CEO Lee Jae-won pose for photos after signing a contract development and manufacturing organization (CDMO) agreement. [MATICA BIOLABS]

Matica Biolabs to manufacture TiCARos' new cancer therapy drugs for clinical trials

CHA Biotech subsidiary Matica Biolabs signed a contract to manufacture medical developer TiCARos' new CAR-T cancer therapy drugs for clinical trials, the companies said Wednesday.

2025.12.10

Samsung Biologics inks $1.29 billion deal as Korean biotech firms scramble amid Trump tariff threat

Samsung Biologics secured a $1.29 billion contract with a U.S. pharmaceutical firm, boosting cumulative orders this year to 5.24 trillion won. Companies like Lotte Biologics and Celltrion also reported significant contracts amid tariff concerns.

2025.9.9

CMG Pharma's Mezofy gets first U.S. FDA approval for changed form for Korea

Mezofy, an oral film-type medication for treating schizophrenia developed by CMG Pharmaceutical, received approval from the U.S. Food and Drug Administration, a first for a change to medication form for a Korean firm.

2025.4.16

Choi Suk-yoon will be appointed as CHA Biotech's vice chair and CEO following shareholder meeting on Monday. [CHA BIOTECH]

CHA Biotech taps former Meritz adviser as vice chairman, CEO

CHA Biotech will appoint Choi Suk-yoon, former adviser at Meritz Securities, as vice chairman and CEO following the general shareholders’ meeting and board approval on Monday.

2025.3.28

CHA Meditech's booth at the Dubai Derma, or Dubai World Dermatology and Laser Conference & Exhibition 2024, which took place in March of last year [CHA BIOTECH]

CHA Meditech continues expansion in aesthetic medicine sector

CHA Meditech is turning to Brazil, a massive aesthetic medicine market, with its hyaluronic acid filler, HyaFilia.

2024.9.26

CHA Biotech CEO Oh Sang-Hoon, right, poses for a photo with Tim Rowe, CEO of Cambridge Innovation Center, after signing an agreement to establish an innovation center for biotech ventures in Pangyo, Gyeonggi. [CHA BIO GROUP]

CHA Bio, Boston's CIC to establish open innovation center for biotech ventures

CHA Bio Group will team up with Boston’s Cambridge Innovation Center to establish an open innovation center to attract biotech ventures worldwide at its cell and gene treatment manufacturing facility currently under construction in Pangyo, Gyeonggi.

2024.5.10

CHA Biotech signs material transfer deal with Chicago-based CanCure

CHA Biotech signed a material transfer deal with a U.S. biotech company to improve the efficacy of its natural killer cell-based cancer treatment.

2024.1.29

From left: Laura Parks, executive vice president of commercial operations at Matica Biotechnology; Heather N. Sugrue, vice president of alliance management [CHA BIOTECH]

U.S. subsidiary of CHA Biotech appoints new executives

Matica Biotechnology, a US subsidiary of CHA Biotech, has appointed Laura Parks as EVP of commercial operations and Heather Sugrue as VP of alliance management to enhance its cell and gene therapy contract manufacturing capabilities.

2023.9.19

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, introduced the MatiMax cell line at the Bio International Convention 2023, or BIO USA, in Boston. [CHA BIOTECH]

Matica Biotechnology introduces self-developed cell line

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, introduced its self-developed cell line MatiMax at the annual BIO International Convention 2023 (BIO USA) taking place in Boston.

2023.6.7

Tag: cha biotech

cha biotech

Latest News

CHA Biotech's U.S. arm launches CDMO platform, bags first client

Matica Biolabs to manufacture TiCARos' new cancer therapy drugs for clinical trials

Most popular

179 dead after Jeju Air flight 7C2216 crashes at Muan International Airport — as it happened

[단독] 삼성SDI 전고체 배터리, 2027년 양산 순항…휴머노이드·모바일까지 확장

Was Son Heung-min benched over media boycott? Whistleblower claims squad rift cost Korea at World Cup.

Ex-football manager Hong Myung-bo leaves for U.S., says his story 'will come out someday'

BigHit Music's new boy band Cortis showcase debut tracks — as it happened